...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Diabetes care >Economic costs of diabetes in the U.S. in 2012
【24h】

Economic costs of diabetes in the U.S. in 2012

机译：美国糖尿病经济成本2012年

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE-This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2012. RESEARCH DESIGN AND METHODS-The study uses a prevalence-based approach that combines the demographics of the U.S. population in 2012 with diabetes prevalence, epidemiological data, health care cost, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, race/ethnicity, insurance coverage, medical condition, and health service category. Data sources include national surveys, Medicare standard analytical files, and one of the largest claims databases for the commercially insured population in the U.S. RESULTS-The total estimated cost of diagnosed diabetes in 2012 is $245 billion, including $176 billion in direct medical costs and $69 billion in reduced productivity. The largest components of medical expenditures are hospital inpatient care (43% of the total medical cost), prescription medications to treat the complications of diabetes (18%), antidiabetic agents and diabetes supplies (12%), physician office visits (9%), and nursing/residential facility stays (8%). People with diagnosed diabetes incur averagemedical expenditures of about $13,700 per year, of which about $7,900 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures approximately 2.3 times higher than what expenditures would be in the absence of diabetes. For the cost categories analyzed, care for people with diagnosed diabetes accounts for more than 1 in 5 health care dollars in the U.S., and more than half of that expenditure is directly attributable to diabetes. Indirect costs include increased absenteeism($5 billion) and reduced productivity while at work ($20.8 billion) for the employed population, reduced productivity for those not in the labor force ($2.7 billion), inability to work as a result of diseaserelated disability ($21.6 billion), and lost productive capacity due to early mortality ($18.5 billion). CONCLUSIONS-The estimated total economic cost of diagnosed diabetes in 2012 is $245 billion, a 41% increase from our previous estimate of $174 billion (in 2007 dollars). This estimate highlights the substantial burden that diabetes imposes on society. Additional components of societal burden omitted from our study include intangibles from pain and suffering, resources from care provided by nonpaid caregivers, and the burden associated with undiagnosed diabetes. ? 2013 by the American Diabetes Association.
机译：目的 - 本研究更新了先前对诊断糖尿病经济负担的估计，并量化了2012年患有患者的卫生资源利用和损失的生产率。研究设计和方法 - 研究采用了基于普遍的方法来结合美国的人口统计学2012年人口患有糖尿病患病率，流行病学数据，医疗保健成本和经济数据成本为糖尿病模型的成本。通过年龄，性别，种族/种族，保险范围，医疗状况和卫生服务类别分析了健康资源使用和相关的医疗费用。数据来源包括国家调查，医疗保险标准分析文件，以及美国成果中商业投保人口的最大索赔数据库之一 - 2012年诊断型糖尿病的总估计成本为2.45亿美元，其中包括1760亿美元的直接医疗费用和69美元亿减少生产率。医疗支出的最大组成部分是医院住院护理（占医疗成本的43％），处方药治疗糖尿病（18％）的并发症（18％），抗糖尿病药剂和糖尿病用品（12％），医生办公室访问（9％）和护理/住宅设施停留（8％）。患有诊断糖尿病的人们每年的平均支出约为13,700美元，其中约7,900美元归因于糖尿病。患有糖尿病患者的人，平均而言，医疗费用高于患有糖尿病的支出高2.3倍。对于分析的成本类别，在美国的患有诊断糖尿病患者中，在美国的55美元中占1人的护理，超过一半的支出是直接归因于糖尿病。间接成本包括增加缺勤（50亿美元），在工作人口上工作（208亿美元）的生产率降低，对劳动力（27亿美元）的生产力降低了生产力，因此由于不排放的残疾而无法工作（216亿美元），由于早期死亡率（185亿美元），损失了生产能力。结论 - 估计2012年诊断型糖尿病的经济总成本为2.45亿美元，我们以前的估计值为1.74亿美元（2007年）增加41％。这种估计突出了糖尿病对社会产生的重大负担。我们的研究中省略的社会负担的其他组成部分包括来自痛苦和痛苦的无形资产，不偿还护理人员提供的资源，以及与未结盟的糖尿病相关的负担。还是2013年由美国糖尿病协会。

著录项

  • 来源
    《Diabetes care》 |2013年第4期|共14页
  • 作者

    YangW.; DallT.M.; HalderP.; GalloP.; KowalS.L.; HoganP.F.; PetersenM.;

  • 作者单位

    Lewin Group Inc. Falls Church VA United States;

    IHS Global Inc. Washington DC United States;

    Lewin Group Inc. United States;

    IHS Global Inc. United States;

    IHS Global Inc. United States;

    Lewin Group Inc. United States;

    American Diabetes Association 1701 N. Beauregard Street Alexandria VA 22311 United States;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号